ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Texas » Neurology

Top Neurology Prescribers in Texas

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
ANNA TSENG MD

Neurology

1,441

$580K

167
123 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

36%
prescriptions for brand name drugs

Avg: 28%

$403
Average prescription price

Avg: $218

DUC TRAN MD

Neurology

2,307

$580K

436
390 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 5%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

48%
prescriptions for brand name drugs

Avg: 28%

$251
Average prescription price

Avg: $218

FLAVIA NELSON M.D.

Neurology

527

$580K

38
15 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

47%
prescriptions for brand name drugs

Avg: 28%

$1100
Average prescription price

Avg: $218

ROBERT ULRICH D.O.

Neurology

997

$571K

144
106 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

46%
prescriptions for brand name drugs

Avg: 28%

$573
Average prescription price

Avg: $218

GANANA TESFA M.D.

Neurology

3,031

$568K

340
261 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

15%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

35%
prescriptions for brand name drugs

Avg: 28%

$187
Average prescription price

Avg: $218

ANJALI SHAH MD

Neurology

632

$562K

64
21 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

37%
prescriptions for brand name drugs

Avg: 28%

$890
Average prescription price

Avg: $218

RANCE BOREN MD

Neurology

2,060

$560K

256
162 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 5%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

29%
prescriptions for brand name drugs

Avg: 28%

$272
Average prescription price

Avg: $218

PETER TARBOX M.D.

Neurology

2,137

$560K

276
154 are 65+

6%
patients receiving schedule two controlled substances

Avg: 2%

9%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

29%
prescriptions for brand name drugs

Avg: 28%

$262
Average prescription price

Avg: $218

TODD MARAIST MD

Neurology

4,200

$556K

490
292 are 65+

4%
patients receiving schedule two controlled substances

Avg: 2%

17%
patients receiving schedule three controlled substances

Avg: 5%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

17%
prescriptions for brand name drugs

Avg: 28%

$132
Average prescription price

Avg: $218

ROBERTO NIETO M.D.

Neurology

3,093

$554K

298
204 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

10%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

46%
prescriptions for brand name drugs

Avg: 28%

$179
Average prescription price

Avg: $218

JAY HARVEY DO

Neurology

1,630

$548K

125
31 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

37%
prescriptions for brand name drugs

Avg: 28%

$336
Average prescription price

Avg: $218

THOMAS TRESE DO

Neurology

2,549

$548K

192
88 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 5%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

30%
prescriptions for brand name drugs

Avg: 28%

$215
Average prescription price

Avg: $218

JOHN FOSTER MD

Neurology

2,117

$541K

234
180 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 5%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

33%
prescriptions for brand name drugs

Avg: 28%

$256
Average prescription price

Avg: $218

ALAN RUBIN MD

Neurology

1,790

$539K

228
173 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

40%
prescriptions for brand name drugs

Avg: 28%

$301
Average prescription price

Avg: $218

TOMMY YEE M.D.

Neurology

2,463

$535K

278
238 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 5%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

42%
prescriptions for brand name drugs

Avg: 28%

$217
Average prescription price

Avg: $218

JULIUS DEIPARINE MD

Neurology

2,109

$535K

303
183 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

41%
prescriptions for brand name drugs

Avg: 28%

$254
Average prescription price

Avg: $218

KHALID MALIK MD

Neurology

2,143

$527K

233
134 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

8%
patients receiving schedule three controlled substances

Avg: 5%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

27%
prescriptions for brand name drugs

Avg: 28%

$246
Average prescription price

Avg: $218

LESTER COLLINS M.D. P.C.

Neurology

2,963

$525K

286
159 are 65+

6%
patients receiving schedule two controlled substances

Avg: 2%

18%
patients receiving schedule three controlled substances

Avg: 5%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

26%
prescriptions for brand name drugs

Avg: 28%

$177
Average prescription price

Avg: $218

CHARLES TUEN M.D.

Neurology

3,915

$524K

301
151 are 65+

6%
patients receiving schedule two controlled substances

Avg: 2%

31%
patients receiving schedule three controlled substances

Avg: 5%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

18%
prescriptions for brand name drugs

Avg: 28%

$134
Average prescription price

Avg: $218

ROBERT MCMICHAEL M.D.

Neurology

1,973

$520K

193
147 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

8%
patients receiving schedule three controlled substances

Avg: 5%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

26%
prescriptions for brand name drugs

Avg: 28%

$264
Average prescription price

Avg: $218

DONALD MILLIGAN

Neurology

4,506

$513K

233
31 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 5%

14%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

18%
prescriptions for brand name drugs

Avg: 28%

$114
Average prescription price

Avg: $218

ERIC PAPPERT M.D.

Neurology

1,054

$513K

120
92 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

35%
prescriptions for brand name drugs

Avg: 28%

$486
Average prescription price

Avg: $218

MICHAEL CLEVENGER MD

Neurology

2,835

$500K

314
220 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

5%
patients receiving schedule three controlled substances

Avg: 5%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

23%
prescriptions for brand name drugs

Avg: 28%

$176
Average prescription price

Avg: $218

.JEFFREY GAITZ M.D.

Neurology

1,290

$497K

174
130 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

35%
prescriptions for brand name drugs

Avg: 28%

$386
Average prescription price

Avg: $218

FERNANDO SANCHEZ M. D.

Neurology

5,131

$496K

712
530 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

6%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

19%
prescriptions for brand name drugs

Avg: 28%

$97
Average prescription price

Avg: $218

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank